COMPARATIVE EFFECTIVENESS OF VEDOLIZUMAB AND USTEKINUMAB IN ANTI-TNF REFRACTORY CROHN'S DISEASE: MULTI-CENTRE RETROSPECTIVE COHORT STUDY

被引：1
|
作者：
Townsend, Tristan [1 ]
Razanskaite, Violeta [2 ]
Michail, Stephanie [1 ]
Morgan, James [1 ]
Davies, Michael [1 ]
Storey, Daniel [1 ]
Watters, Christopher [3 ]
Penman, Douglas [3 ]
Swaminathan, Mira [4 ]
Reilly, Ian [4 ]
Flanagan, Paul
Subramanian, Sreedhar [1 ]
机构：
[1] Royal Liverpool Univ Hosp, Liverpool, Merseyside, England
[2] Aintree Univ Hosp NHS Fdn Trust, Liverpool, Merseyside, England
[3] Arrowe Pk Hosp, Upton, England
[4] Countess Chester Hosp, Chester, Cheshire, England
来源：
GUT | 2021年 / 70卷
关键词：
D O I：
10.1136/gutjnl-2020-bsgcampus.237
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P162
引用
收藏
页码：A127 / A127
页数：1
相关论文
共 50 条
  • [21] ACCELERATED DOSING SCHEDULE WITH USTEKINUMAB IN ANTI-TNF REFRACTORY CROHN'S DISEASE
    Gonzalez, Haidee Aleman
    Stamp, Katie
    Whitehead, Emma
    Myers, Sally
    Turnbull, Jack
    Pattinson, Alison
    Talbot, Alison
    Sebastian, Shaji
    GUT, 2021, 70 : A98 - A98
  • [22] Accelerated dosing schedule with ustekinumab in anti-TNF refractory Crohn's disease
    Gonzalez, H. Aleman
    Stamp, K.
    Whitehead, E.
    Pattinson, A.
    Turnbull, J.
    Myers, S.
    Talbot, A.
    Sebastian, S.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I374 - I375
  • [23] Correction: Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study
    Cassandra Rayer
    Maria Nachury
    Arnaud Bourreille
    Xavier Roblin
    Laurent Peyrin-Biroulet
    Stephanie Viennot
    Mathurin Flamant
    David Laharie
    Bénédicte Caron
    Marie Dewitte
    Laurent Siproudhis
    Mathurin Fumery
    Guillaume Bouguen
    BMC Gastroenterology, 23
  • [24] Letter: effectiveness of ustekinumab or vedolizumab in Crohn's disease following anti-TNF failure-getting closer to the truth?
    Liu, Kecheng
    Cai, Fuqing
    Huang, Jiean
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (07) : 1253 - 1254
  • [25] Comparison of vedolizumab and ustekinumab treatment persistence in anti-TNF experienced Crohn's Disease patients
    Eroglu, Z.
    Yilmaz, V.
    Er, R. E.
    Soykan, I.
    Toruner, M.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1182 - I1182
  • [26] LONG-TERM CLINICAL EFFICACY OF USTEKINUMAB IN REFRACTORY CROHN'S DISEASE: A MULTI-CENTRE BELGIAN COHORT STUDY
    Liefferinckx, Claire
    Verstockt, Bram
    Gils, Ann
    Noman, Maja
    Van Kemseke, Catherine
    Macken, Elisabeth
    De Vos, Martine
    Van Moerkercke, Wouter
    Rahier, Jean-Francois
    Bossuyt, Peter
    Dutre, Joris
    Humblet, Evelien
    Staessen, Dirk
    Peeters, Harald
    Van Hootegem, Philippe
    Louis, Edouard
    Franchimont, Denis
    Baert, Filip J.
    Vermeire, Severine
    GASTROENTEROLOGY, 2019, 156 (06) : S882 - S883
  • [27] Comparative Effectiveness of Ustekinumab Versus Vedolizumab in Treating Crohn's Disease After Failure of Anti-TNF Agents: Real-World Evidence
    Alamer, A.
    Al Lehaibi, L.
    Alomar, M.
    Aldhuwayan, F.
    Alshouish, S.
    Al-Ali, A.
    Almudhry, Z.
    Almulhim, A.
    Althagafi, A.
    Aldosari, S.
    Alameel, T.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1297 - I1297
  • [28] Long-term clinical efficacy of ustekinumab in refractory Crohn's disease : a multi-centre Belgian cohort study
    Liefferinckx, C.
    Verstockt, B.
    Gils, A.
    Noman, M.
    Van Kemseke, C.
    Macken, E.
    De Vos, M.
    Van Moerkercke, W.
    Rahier, J. -F.
    Bossuyt, P.
    Dutre, J.
    Humblet, E.
    Staessen, D.
    Peters, H.
    Van Hootegem, P.
    Louis, E.
    Franchimont, D.
    Baert, F.
    Vermeire, S.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S44 - S45
  • [29] The Use of Combination Vedolizumab and Ustekinumab in Crohn's Disease: A Retrospective Cohort Study
    Glassner, Kerri
    Wang, Lin
    Ezeana, Chika
    Wong, Stephen
    Abraham, Bincy P.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S355 - S355
  • [30] Short term effectiveness of ustekinumab versus vedolizumab in Crohn's disease after failure of anti-TNF agents: An observational comparative study design with a Bayesian analysis
    Alamer, Ahmad
    Al Lehaibi, Lina H.
    Alomar, Mukhtar
    Aldhuwayan, Fahad
    Alshouish, Saleh
    Al-Ali, Anfal Y.
    Almudhry, Zakia
    Almulhim, Abdulaziz
    Althagafi, Abdulhamid
    Aldosari, Saad
    AlAmeel, Turki
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2024, 30 (05): : 324 - +
12345